Treatment of acromegaly in: * Patients already adequately controlled on standard doses of Sandostatin s.c. * Patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective.* Endocrine gastro-entero- pancreatic (GEP) tumors, carcinoid tumors.